The global exoskeleton market size was estimated at USD 498.33 million in 2024 and is projected to reach USD 1.25 billion by 2030, growing at a CAGR of 16.27% from 2025 to 2030. Several key factors are contributing to this strong market expansion. These include the rapidly increasing global geriatric population, which is more prone to mobility-related challenges; the rising adoption of advanced medical devices across industries such as automotive, military, defense, and construction; and the growing number of individuals affected by stroke. Together, these elements are creating widespread demand for exoskeleton solutions across both healthcare and industrial settings.
Additionally, the rising incidence of spinal cord injuries (SCI) continues to significantly influence market demand. For example, according to the National Spinal Cord Injury Statistical Center (NSCISC), the U.S. reports 17,730 new SCIs annually, with approximately 291,000 individuals living with SCI-related disabilities. Such conditions often impair mobility and physical strength, making exoskeleton devices an essential tool for rehabilitation and improved quality of life.
Exoskeleton technologies are also being widely adopted across various industries to enhance employee safety, support physical well-being, and improve workplace productivity. This growing adoption has encouraged the emergence of numerous startups specializing in exoskeleton development, particularly those focusing on rehabilitation-based solutions. As the industry continues to evolve, market players are prioritizing innovation and developing advanced product strategies to accelerate adoption over the forecast period. For instance, in June 2022, Ekso Bionics received 510(k) FDA clearance for the marketing of EksoNR, a next-generation robotic exoskeleton designed to support the rehabilitation of patients with multiple sclerosis.
Moreover, the increasing prevalence of spinal cord injury remains a major driver of exoskeleton adoption. Patients with SCI are frequently recommended to use exoskeleton devices as part of their rehabilitation programs to improve mobility, build muscle strength, and enhance functional outcomes. This rising need is encouraging both patients and healthcare providers to integrate exoskeletons into treatment plans. According to the World Health Organization, an estimated 250,000–500,000 people worldwide suffer from spinal cord injury each year, and this growing patient population is directly contributing to the increasing use of exoskeleton technologies globally.
Key Market Trends & Insights:
North America led the global exoskeleton market in 2024, accounting for 45.13% of the total revenue and 26.32% of the overall volume share. This strong regional dominance is attributed to high awareness of advanced rehabilitation technologies, strong healthcare infrastructure, and early adoption of innovative medical and industrial exoskeleton systems. The presence of leading manufacturers and supportive regulatory frameworks further strengthens the region’s market position.
Within North America, the U.S. emerged as the dominant country in the regional exoskeleton market. The country benefits from high R&D investment, greater availability of clinical rehabilitation centers, and a large patient population requiring mobility assistance due to conditions such as spinal cord injuries, stroke, and neurodegenerative diseases. Industrial sectors in the U.S. are also increasingly integrating exoskeletons to enhance worker safety and reduce physical strain.
Based on mobility, the mobile segment led the market in 2024, capturing the largest revenue share of 62.39%. This dominance reflects the rising demand for exoskeletons that enable user movement, support gait training, and assist patients with mobility impairments. Mobile exoskeletons are widely used for rehabilitation purposes, workplace support, and military applications, further driving their strong market position.
By extremity, the lower body segment dominated the market in terms of revenue share. Lower body exoskeletons are heavily utilized for assisting gait, improving balance, and supporting mobility rehabilitation for individuals with lower limb disabilities or paralysis. Their extensive adoption in medical rehabilitation centers and among patients with spinal cord injuries contributes significantly to the segment’s continued leadership.
Order a free sample PDF of the Exoskeleton Market Intelligence Study, published by Grand View Research.
Market Size & Forecast:
• 2024 Market Size: USD 498.33 Million
• 2030 Projected Market Size: USD 1.25 Billion
• CAGR (2025-2030): 16.27%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market
Key Companies & Market Share Insights:
Key players who prioritize innovation, continuous product development, and strategic partnerships to strengthen their competitive advantage continue to dominate the exoskeleton market. These companies consistently invest in advanced technologies and collaborative initiatives to expand their product portfolios and address evolving industry needs.
For instance, in March 2023, Svaya Robotics developed a quadruped robot along with a wearable exoskeleton. The exoskeleton is specifically engineered to align with the body structure of Indian soldiers, enabling enhanced physical strength and endurance. It supports soldiers in walking long distances with reduced fatigue and assists them in carrying heavy loads with less effort, demonstrating a practical application of exoskeleton technology in military operations.
The market share is largely concentrated among well-established players that possess significant resources for research and development (R&D) and have the capability to introduce highly advanced and reliable exoskeleton systems. These leading companies benefit from strong technological expertise, global networks, and large-scale production capabilities. Meanwhile, emerging players in the market are increasingly focusing on cost-effective solutions and technological improvements to gain traction. By offering affordable yet innovative products, they aim to attract a broader customer base and compete effectively with the major industry leaders.
Key Players
• Ekso Bionics
• ARMASTEC PTE. LTD
• Hocoma
• Lockheed Martin Corporation
• Suit X
• Rex Bionics Plc.
• RB3D
• ReWalk Robotics
• Cyberdyne, Inc.
• ActiveLink (Panasonic Corporation)
• DIH Medical
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion:
The exoskeleton market is poised for strong long-term growth driven by rising demand in healthcare, industrial, and defense sectors. Increasing cases of mobility disorders, workplace safety needs, and advancements in robotics continue to support wider adoption. Technological innovations, especially in powered and mobile exoskeletons, are enhancing usability and expanding application areas. However, high costs, comfort limitations, and the need for specialized training remain key challenges that may impact adoption. Overall, the market is expected to progress steadily as companies focus on improving performance, reducing costs, and making exoskeleton systems more accessible and user-friendly.
